The triple negative breast cancer (TNBC) treatment market is estimated to be valued at USD 1000 million in 2024 and is expected to reach USD 1432 million by 2031, growing at a compound annual growth rate (CAGR) of 5.3% from 2024 to 2031. https://logcla.com/blogs/462588/Triple-Negative-Breast-Cancer-TNBC-Treatment-Market-is-Anticipated-to